Study to Evaluate the Safety and Efficacy of Dermal Injections of JVS-100 Given to Adults Receiving Median Sternotomy

ClinicalTrials.gov ID: NCT01657045

Public ClinicalTrials.gov record NCT01657045. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jun 26, 2026, 5:30 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase I Randomized, Double-Blind, Placebo Controlled Dose Escalation Study to Evaluate the Safety and Efficacy of JVS-100 Administered by Needle-free Dermal Injection to Cohorts of Adults Receiving Surgical Sternotomy Incisions

Study identification

NCT ID: NCT01657045
Recruitment status: Not listed
Study type: Interventional
Phase: Phase 1
Lead sponsor: SironRX Therapeutics, Inc.; Industry
Enrollment: 25 participants

Conditions and interventions

Conditions

Median Sternotomy

Interventions

JVS-100 or placebo Biological

Biological

Eligibility (public fields only)

Age range: 40 Years to 80 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jun 30, 2012
Primary completion: Nov 30, 2013
Completion: Jun 30, 2014
Last update posted: Jul 22, 2013

2012 – 2014

United States locations

U.S. sites: 6
U.S. states: 6
U.S. cities: 6

Facility	City	State	ZIP	Site status
Pepin Heart Institute	Tampa	Florida	33613	Recruiting
Northwestern University Bluhm Cardiovascular Inst	Chicago	Illinois	60611	Recruiting
Montefiore Medical Center	New York	New York	10467	Recruiting
Summa Health System Hospital	Akron	Ohio	44304	Recruiting
University of Utah Hospital	Salt Lake City	Utah	84132	Recruiting
Sentara Cardiovascular Research Institute	Norfolk	Virginia	23507	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT01657045, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Jul 22, 2013 · Synced Jun 26, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01657045 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →